TimeScale Financial’s Repligen RGEN Stock Holding History

TimeScale Financial’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-86	Closed	-$7K	–	513
2019 Q4	$7K	Buy	+86	New	+$7.22K	﹤0.01%	397

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

TimeScale Financial's RGEN Position: Q1 2020 in Review

TimeScale Financial sold out of Repligen (RGEN) in Q1 2020, closing a stake of 86 shares — an estimated $7K sold.

TimeScale Financial first reported a position in RGEN in Q4 2019 and held it in 1 quarter. The position peaked at $7K in Q4 2019. 309 funds tracked by Wall St. Rank hold RGEN as of Q1 2020.

TimeScale Financial reported no remaining Repligen position as of Q1 2020 after selling out during the quarter.
TimeScale Financial sold 86 Repligen shares in Q1 2020, an estimated $7K.
TimeScale Financial first reported a position in Repligen in Q4 2019 and held it in 1 quarter.
TimeScale Financial's Repligen position peaked at $7K in Q4 2019.
309 funds tracked by Wall St. Rank held Repligen as of Q1 2020.

Based on TimeScale Financial's 13F filing for Q1 2020, filed 9 Apr 2020.